Clinical trial / 2011
Vitamin E's effect on pneumonia risk varied significantly by smoking and exercise habits in male smokers.
In the ATBC Study, 29,133 male smokers aged 50-69 years received vitamin E (50 mg/day), beta-carotene (20 mg/day), both, or placebo for a median of 6.0 years. Subgroup analyses tested the effect on hospital-treated pneumonia across groups defined by smoking amount, age of initiation, and leisure exercise. Vitamin E decreased pneumonia risk by 69% (95% CI: 43% to 83%) in those with the least smoking exposure who exercised, but increased pneumonia risk by 79% (95% CI: 27% to 150%) among those with the highest smoking exposure who did not exercise. The authors noted that it is not evident to what extent effect estimates or subgroup boundaries can be extrapolated to other populations.
- Study type
- Randomized 2x2 factorial trial (subgroup analysis)
- Who was studied
- 29,133 male smokers aged 50-69 years
- What was measured
- Risk of hospital-treated pneumonia (898 cases)
THE PAPER
Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia.
Hemilä H, Kaprio J. Clin Epidemiol, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.